Bernstein Sticks with 'Outperform' on UnitedHealth Amid AI Growth Potential
Bernstein SocGen Group has reaffirmed its 'Outperform' rating and $512.00 price target on UnitedHealth Group (NYSE:UNH), citing the company's strong momentum and potential growth engine in Optum Insight.
Optum Insight, a collection of businesses providing technology, analytics, and revenue cycle management services to healthcare providers and payers, is seen as crucial to UnitedHealth's long-term growth story for three reasons, according to Bernstein. Firstly, it represents a potential growth engine beyond the current recovery in Medicare Advantage and value-based care.
Secondly, its business mix and growth drivers are distinct from UnitedHealth and Optum Health, making it a differentiated source of earnings growth. Lastly, Optum Insight is viewed as having the largest potential upside to the application of AI to healthcare businesses, with significant long-term opportunity for UnitedHealth and Optum Insight.